Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Gross Profit (2010 - 2013)

Updated

Northwest Biotherapeutics (NWBO) recorded Gross Profit of $809,000 in FY2013, up 4.8% from $772,000 in FY2012.

Analysis

Northwest Biotherapeutics (NWBO) Gross Profit (2010 - 2013) Analysis & Trends

Starting with FY2010, Northwest Biotherapeutics' Gross Profit history includes 4 years.

  • Annual Gross Profit has a three-year compound annual growth rate of 332.5% (FY2010 to FY2013).
  • Per Business Quant data, NWBO's Gross Profit was $772,000 in FY2012, $10,000 in FY2011 (unchanged) and $10,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 400,000.00
Jun 30, 2013 272,000.00
Mar 31, 2013 137,000.00
Dec 31, 2012 322,000.00
Sep 30, 2012 120,000.00
Jun 30, 2012 330,000.00
Sep 30, 2011 10,000.00
Sep 30, 2010 10,000.00
API Access

Northwest Biotherapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=NWBO&period=max&api_key=YOUR_API_KEY